Skip to content

Osteo Pro

Active
Private limited companyfounded 2023active for 3 yearsTerlaenenstraat(OTT) 75, 3040 Huldenberg, BelgiumKBO/BCE: BE 0803.693.005
Summary

Osteo Pro has been active since 2023 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €10,853 and a net result of €8,369. Its solvency ranks better than 40% of 20,700 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).

Overview

Overview

Official details

Source: KBO
Status
Active since 06-07-2023 Normal situation
Activity
Physiotherapy NACE 86951and 5 others
Establishment unit
2.349.575.471 3040 Huldenberg, since 06-07-2023
Financial year end
30 June
Peppol
Reachable since 05-09-2025

Board and ownership

Board

Financial position

96 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
< 0.1%
Annual accounts to 30-06-2025
Gross margin
€13,729
▼ 4.7%
Turnover
≈ €83,000
estimated
Profit
€8,369
▼ 22.6%
Equity
€10,853
▲ 227%
Total assets
€21,223
▲ 0.3%
Score breakdownraises riskFounded in 2023lowers riskSector: Human health activities (NACE 86)Liquidity: current ratio 1.83, cash €13,184Equity €10,853 (51.1% of total assets)Show the evidence

Checked score

Score 2025
96 / 100
Excellent
Probability in this band: under 0.55%
Financially stronger than 68% of micro companies in human health (NACE 86)
Financial strength · tick: 2024
Strong
Solvency 76+35
equity 51.1% of total assets
Liquidity 76+15
short-term debt 48.9% · cash 62.1%
Profitability 100=
return on assets 39.4%
Bankruptcy probability within 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (24,160 companies, NACE 86, micro)
Last 24 months 12-2024: 0.7%highest value 01-2025: 0.7%● unchanged vs 12-2024highest value 02-2025: 0.1%▼ -0.6 percentage points vs 01-2025 03-2025: 0.1%● unchanged vs 02-2025 04-2025: 0.1%● unchanged vs 03-2025 05-2025: 0.1%● unchanged vs 04-2025 06-2025: 0.1%● unchanged vs 05-2025 07-2025: 0.1%● unchanged vs 06-2025 08-2025: 0.1%● unchanged vs 07-2025 09-2025: 0.1%● unchanged vs 08-2025 10-2025: 0.1%● unchanged vs 09-2025 11-2025: 0.1%● unchanged vs 10-2025 12-2025: 0.1%● unchanged vs 11-2025 01-2026: 0.2%▲ +0.1 percentage points vs 12-2025 02-2026: 0.1%▼ -0.1 percentage points vs 01-2026 03-2026: < 0.1%▼ -0.1 percentage points vs 02-2026 04-2026: < 0.1%● unchanged vs 03-2026 05-2026: < 0.1%● unchanged vs 04-2026 06-2026: < 0.1%● unchanged vs 05-2026 07-2026: < 0.1%● unchanged vs 06-2026 08-2026: < 0.1%● unchanged vs 07-2026lowest value 09-2026: < 0.1%● unchanged vs 08-2026 10-2026: < 0.1%● unchanged vs 09-2026 11-2026: < 0.1%● unchanged vs 10-2026
Credit of up to €1,000 on 30-day terms is acceptable
Liquidity is ample, with a current ratio of 1.83 (1.38 in 2024), above the usual 1.5. Short-term debt is 48.9% and cash 62.1% of total assets. 48.9% of the assets are financed with debt and provisions.
Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro). It does better than 41% of them on solvency, 57% on liquidity, 80% on profitability and 95% on growth.

The bankruptcy probability was computed on 01-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Five signals.
lowers riskraises riskneutral
lowers risk · Sector: Human health activities (NACE 86)
KBO
lowers risk · Liquidity: current ratio 1.83, cash €13,184
NBB · annual accounts
raises risk · Founded in 2023
Companies of this age fail more often than older ones. How much that weighs depends on the rest of the company's profile.
KBO
lowers risk · Equity €10,853 (51.1% of total assets)
NBB · annual accounts
neutral · Latest accounts filed on time
The financial year that closed on 30-06-2025 was due by 31-01-2026 and was filed on 27-01-2026, 4 days ahead of the deadline.
NBB · 2 filings
Deviation from the deadline
2025
4 days early
2024
3 days early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

The company filed its last 2 accounts on average 4 days before the deadline. In the sector (NACE 86), the median for financial year 2024 was 7 days before the deadline, and 36% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The financial year that closed on 30-06-2026 is due by 31-01-2027. Nothing is late today.
Companies Code · seven months
Where today falls in the filing period
30-06-2026 year end02-11-2026 today31-01-2027 deadline
neutral · No strike-offs in the KBO publications
That holds for every publication since incorporation in 2023.
KBO publications

Financials

Financials · financial year 2025, micro format

Annual accounts 2025 filed on 27-01-2026 PDF all 2 filings

Turnover
≈ €83,000
Estimated: probably between €55,000 and €140,000
Total assets
€21,223▲ 0.3%
2024 · €21,159
Net result
€8,369▼ 22.6%
2024 · €10,817
Working capital
€8,632▲ 48.4%
2024 · €5,817
Trend over the years

2024 to 2025, 2 financial years

The operating result for 2025 is 3% lower than in 2024.

Operating result€12,411 2025 Net result€8,369 2025

Turnover is what the company sold, the result is what was left of it. A loss stands below the zero line.

Use the arrow keys on the chart for the figures per year.

The sector band is the middle half of the companies in Human health activities (NACE 86). A quarter of them sit below it, a quarter above. Each year counts only accounts in the same format, and only where there are at least 30. The dashed line is the median. There is a sector band for net result, equity, total assets, working capital, solvency, current ratio and return on assets (ROA).

Every figure with its change against the financial year before
favourable unfavourable
Line20242025
Operating result€12,831-€12,411▼ 3.3%
Net result€10,817below the sector's middle half-€8,369below the sector's middle half▼ 22.6%
Equity€3,317below the sector's middle half-€10,853below the sector's middle half▲ 227%
Total assets€21,159below the sector's middle half-€21,223below the sector's middle half▲ 0.3%
Debt€17,841-€10,370▼ 41.9%
Working capital€5,817below the sector's middle half-€8,632below the sector's middle half▲ 48.4%
Solvency15.7%below the sector's middle half-51.1%within the sector's middle half▲ 35.5pp
Current ratio1.38below the sector's middle half-1.83within the sector's middle half▲ 0.45
Return on assets (ROA)51.1%above the sector's middle half-39.4%within the sector's middle half▼ 11.7pp
above within below The sector band is the middle half of the companies in Human health activities (NACE 86). A quarter of them sit below it, a quarter above. Each year counts only accounts in the same format, and only where there are at least 30.
Turnover and EBIT margin are not published. The micro format does not require them. The turnover shown is an estimate from the gross margin.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €21,223
Fixed assets €2,221
Current assets €19,002
Equity and liabilities €21,223
Equity €10,853 ▲ 227%
Debt €10,370 ▼ 41.9%
Debt's share of the balance-sheet total falls from 84.3% to 48.9%. Equity is higher and debt is lower.
Key figures and ratios
2025 value · change against 2024
EBITDA
€12,578▼
2024 · €14,338
Cash flow
€8,536▼
2024 · €12,324
Debt to equity
0.96▼
2024 · 5.38
ROE
77.1%▼
2024 · 326.1%
Interest coverage
56.17▼
2024 · over 100
Debt ≤ 1 year
€10,370▼
2024 · €15,341
Income taxes
€3,818▲
2024 · €2,007
Green means a favourable move, even when the figure itself falls, as with debt or debt to equity.

Investments

fixed assets acquired
Item30-06-202430-06-2025
Tangible fixed assets-€2,388
Depreciation and write-downs of the year€1,507€167

Source: notes to the 2024 to 2025 annual accounts (statement of fixed assets)

Annual accounts
Filed annual accounts As filed with the NBB · 2025 against 2024 · 41 lines
Balance sheet Code20242025
Assets
Total assets20/58€21,159€21,223▲
Fixed assets21/28-€2,221
Tangible fixed assets22/27-€2,221
Furniture and vehicles24-€2,221
Current assets29/58€21,159€19,002▼
Amounts receivable within one year40/41€1,594€4,604▲
Trade receivables40-€1,128
Other amounts receivable41€1,594€3,476▲
Cash at bank and in hand54/58€18,677€13,184▼
Deferred charges and accrued income490/1€888€1,213▲
Equity and liabilities
Total equity and liabilities10/49€21,159€21,223▲
Equity10/15€3,317€10,853▲
Contributions10/11€2,500€2,500=
Profit (loss) carried forward14€817€8,353▲
Amounts payable17/49€17,841€10,370▼
Amounts payable within one year42/48€15,341€10,370▼
Financial debts43€1,309€2,131▲
Credit institutions430/8€1,309€2,131▲
Trade debts44€481€915▲
Suppliers440/4€481€915▲
Taxes, remuneration and social security45€4,952€44▼
Taxes450/3€4,952€44▼
Other amounts payable47/48€8,600€7,280▼
Accrued charges and deferred income492/3€2,500-
Income statement Code20242025
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€1,507€167▼
Other operating charges640/8€63€1,151▲
Gross operating margin9900€14,401€13,729▼
Operating profit (loss)9901€12,831€12,411▼
Financial income75/76B€6-
Recurring financial income75€6-
Financial charges65/66B€13€224▲
Recurring financial charges65€13€224▲
Profit (loss) for the period before taxes9903€12,824€12,187▼
Income taxes67/77€2,007€3,818▲
Profit (loss) for the period9904€10,817€8,369▼
Profit (loss) for the period to be appropriated9905€10,817€8,369▼
Appropriation of the result
Profit (loss) to be appropriated9906€10,817€9,186▼
Profit (loss) brought forward from the previous period14P-€817
Profit to be distributed694/7€10,000€833▼
Return on contributions (dividend)694-€833
Directors or managers695€10,000-

The notes to these accounts have 5 items, including the statement of assets and debts, the cost breakdown and rights and commitments. You find them in the filed accounts (PDF).

Source: Annual accounts 2025 (PDF), filed on 27-01-2026.

Line20242025Change
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€1,507€167▼ 88.9%
Other operating charges640/8€63€1,151▲ 18×
Gross operating margin9900€14,401€13,729▼ 4.7%
Operating profit (loss)9901€12,831€12,411▼ 3.3%
Financial income75/76B€6--
Recurring financial income75€6--
Financial charges65/66B€13€224▲ 18×
Recurring financial charges65€13€224▲ 18×
Profit (loss) for the period before taxes9903€12,824€12,187▼ 5.0%
Income taxes67/77€2,007€3,818▲ 90.2%
Profit (loss) for the period9904€10,817€8,369▼ 22.6%
Profit (loss) for the period to be appropriated9905€10,817€8,369▼ 22.6%
Line20242025Change
Assets
Total assets20/58€21,159€21,223▲ 0.3%
Fixed assets21/28-€2,221-
Tangible fixed assets22/27-€2,221-
Furniture and vehicles24-€2,221-
Current assets29/58€21,159€19,002▼ 10.2%
Amounts receivable within one year40/41€1,594€4,604▲ 189%
Trade receivables40-€1,128-
Other amounts receivable41€1,594€3,476▲ 118%
Cash at bank and in hand54/58€18,677€13,184▼ 29.4%
Deferred charges and accrued income490/1€888€1,213▲ 36.7%
Equity and liabilities
Total equity and liabilities10/49€21,159€21,223▲ 0.3%
Equity10/15€3,317€10,853▲ 227%
Contributions10/11€2,500€2,500=
Profit (loss) carried forward14€817€8,353▲ 922%
Amounts payable17/49€17,841€10,370▼ 41.9%
Amounts payable within one year42/48€15,341€10,370▼ 32.4%
Financial debts43€1,309€2,131▲ 62.8%
Credit institutions430/8€1,309€2,131▲ 62.8%
Trade debts44€481€915▲ 90.3%
Suppliers440/4€481€915▲ 90.3%
Taxes, remuneration and social security45€4,952€44▼ 99.1%
Taxes450/3€4,952€44▼ 99.1%
Other amounts payable47/48€8,600€7,280▼ 15.3%
Accrued charges and deferred income492/3€2,500--
Line20242025Change
Profit (loss) for the period9904€10,817€8,369▼ 22.6%
+ Depreciation and write-downs630€1,507€167▼ 88.9%
Operating cash flow (approximation)€12,324€8,536▼ 30.7%
Change in cash--€5,492-

A Belgian filing has no cash-flow statement. These rows are therefore an approximation, derived from the income statement and the balance-sheet moves.

Download as CSV

Historical observation

In July 2024, 39,278 companies had the same profile as Osteo Pro has now. Two years later, 1.8% had gone bankrupt and 95.9% were still going.

  • Micro
  • 2 to 5 years old
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more
1.8% went bankrupt
2.3% stopped otherwise
95.9% was still going

The bankruptcy probability of Osteo Pro itself is lower: < 0.1% within 12 months. It rests on far more data about Osteo Pro than the profile alone.

Test of the method

The method was tested on the 497,446 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 3.0% 3.1%
10 5.6% 6.2%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 39,278 companies, not a prediction for Osteo Pro. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Filings with the National Bank (2)
Financial year Type Filed Reference Document
30-06-2025 micro format 27-01-2026 2026-00015489 PDF
30-06-2024 micro format 28-01-2025 2025-00011764 PDF

Board & ownership

Directors

Directors
1 director, no change since 2023
Sven Onclinx
Director (not named in the articles) · appointed in the act of 10-07-2023 · term without a fixed end · listed in the 2025 annual accounts, filed on 27-01-2026
Current
Signing authorityThe articles say who may bind the company, for example by signing a contract.
“Deux administrateurs : Lorsque la société est administrée par deux administrateurs, chaque administrateur agissant seul, peut accomplir tous…”
“administration collégial. L’organe d’administration collégial représente la société à l'égard des tiers et en justice, soit en demandant…”
Full text

administration collégial. L’organe d’administration collégial représente la société à l'égard des tiers et en justice, soit en demandant, soit en défendant. L’organe d’administration collégial peut déléguer des pouvoirs spéciaux à tout mandataire. Pouvoir de représentation Un ou deux administrateurs : Chaque administrateur représente la société à l'égard des tiers et en justice, soit en demandant, soit en défendant. Il peut déléguer des pouvoirs spéciaux à tout mandataire.

“Trois (ou plus) administrateurs : La société est représentée à l’égard des tiers et en justice, soit en demandant, soit en défendant, par la…”
Full text

Trois (ou plus) administrateurs : La société est représentée à l’égard des tiers et en justice, soit en demandant, soit en défendant, par la majorité de ces administrateurs. La majorité des administrateurs peut déléguer des pouvoirs spéciaux à tout mandataire. ASSEMBLEE GENERALE

deed of 10-07-2023

Owners and capital

Shareholders

At incorporation act of 10-07-2023 ↗
  • ONCLINX Sven Stefan Fernand 100 shares (100%) · €2,500

Capital transactions

Capital over time
  1. 10-07-2023 Incorporation · €2,500 · 100 shares

Articles of association

Transfer restrictionThis rule says whether shareholders may sell their shares freely or need approval first.
“Helft overdrager en helft koper(s) naar evenredigheid verworven aantal bij meer kopers, elke overdracht onder levenden ten bezwarende of…”
deed of 01-03-2024 (in Dutch)
Statutory auditorA statutory auditor is a registered auditor who checks the annual accounts. Small companies need not have one.
No statutory auditor
deed of 10-07-2023 (in French)

Network & group

Connections & network

1 connected company
Depth

The connected companies are in the list below.

This company Company Director Shareholding +N: links not shown yet Click a node to look further, drag to arrange, zoom with the mouse wheel.
Linked via shared directors

Timeline

Acts, filings and financial milestones

Deadline for the 2026 accounts: 31-01-2027
2026
27-01
NBB filing Annual accounts 2025 filedPDF
micro format · 4 days before the deadline
2025
28-01
NBB filing Annual accounts 2024 filedPDF
micro format · 3 days before the deadline
2024
01-03
Gazette deed Amendment of the articles · Resignations & appointments
Registered office clause4 points ▸
  • General meeting, 08-12-2023
  • Other provision, “vertaling voorwerp vennootschap naar het Nederlands, Tweede besluit” (deed in Dutch)
  • Other provision, “Nederlandstalige versie van de statuten aangenomen die tevens zal gelden als coördinatie, Derde besluit” (deed in Dutch)
  • Registered office clause, “Terlaenenstraat 75”, 3040 (deed in Dutch)

Open the act in the Belgian Official Gazette

02-02
Gazette deed Registered office
Registered-office move2 points ▸
  • General meeting, 08-12-2023
  • Registered-office move, Région Flamande

Open the act in the Belgian Official Gazette

2023
10-07
Gazette deed Incorporation
Starting capital €2,500 · Appointment: ONCLINX Sven Stefan Fernand (director) · Founder10 points ▸
  • Incorporation, 05-07-2023
  • Founder, ONCLINX Sven Stefan Fernand
  • Founding capital, €2,500
  • Bank account, “Banque Belfius SA, BE83 0689 4931 8415” (deed in French)
  • ONCLINX Sven Stefan Fernand holds 100 shares
  • Other provision, “dispositions finales et transitoires, comparant à l’unanimité” (deed in French)
  • Registered office clause, “Clos Marquis de Bethune 8,1310 La Hulpe”, 2 (deed in French)
  • Board rule, 1, “assemblée” (deed in French)
  • Director appointment, ONCLINX Sven Stefan Fernand (director (not named in the articles))
  • Declaration, “capacité mandat, ne pas être frappé d’aucune restriction de sa capacité d’exercer ledit mandat” (deed in French)

Open the act in the Belgian Official Gazette

Gazette deedNBB filing

Sources:Publications in the Belgian Official GazetteFilings with the National Bank

History

On 6 July 2023, Osteo Pro was incorporated as a private limited company by one natural person, with a starting capital of €2,500.12 Sven Onclinx is director of the company, appointed in the act of 10-07-2023.2 The company has filed 2 sets of annual accounts, the latest for financial year 2025.3

  1. 1KBO register
  2. 2Belgian Official Gazette, 10-07-2023
  3. 3National Bank, annual accounts 2025

Company details

Register details

Identity

KBO record
Name Osteo Pro in French
Enterprise number 0803.693.005
Legal form Private limited company
Status Active, normale toestand
Founded 06-07-2023
Entity type Legal entity
DurationMost companies exist for an unlimited period, until they are dissolved.
Unlimited
deed of 10-07-2023 (in French)
Name clauseThe company operates under this name according to its articles.
Osteo Pro
deed of 01-03-2024 (in Dutch)
Registered office clauseThe articles name the region of the registered office. The language of official documents depends on that region, among other things.
“Bij enkel besluit van het bestuursorgaan administratieve zetels,agentschappen,werkhuizen,stapelplaatsen en bijkantoren vestigen in België of…”
deed of 01-03-2024 (in Dutch)

Registered office and establishments

Registered office Terlaenenstraat(OTT) 75, 3040 Huldenberg, Belgium
Establishment unit OsteoPro BV, Terlaenenstraat(OTT) 75, 3040 Huldenberg since 06-07-2023 · unit number 2.349.575.471

Activities

NACEBEL 2025
86951 Physiotherapy main activity
85592 Vocational training
86920 Human health activities
86995 Nutrition and dietetics services
96993 Pet care services, excluding veterinary services
96999 Other personal services
Codes under NACEBEL 2008
86905 Human health activities main activity
85592 Vocational training
86903 Human health activities
86909 Human health activities
96093 Personal service activities
96099 Personal service activities
PurposeThe purpose describes the activities the company may carry out under its articles.
“De uitoefening van kinesitherapie en elke activiteit die rechtstreeks of onrechtstreeks verband houdt met kinesitherapie; De uitoefening van…”
21 activities
  1. De uitoefening van kinesitherapie en elke activiteit die rechtstreeks of onrechtstreeks verband houdt met kinesitherapie.
  2. De uitoefening van de osteopathie in al haar toepassingsgebieden die rechtstreeks of onrechtstreeks betrekking hebben op het ontwerp,de organisatie en de werking van een osteopathische praktijk,met inbegrip van,maar niet beperkt tot,de samenwerking met andere medische en/of paramedische disciplines in overeenstemming met de ethische voorschriften.
  3. Werken als een medische en paramedische entiteit op het gebied van de revalidatie van patiënten,evenals elke discipline die de gezondheid van het individu kan verbeteren.
  4. De exploitatie van fysiotherapiepraktijken en het aanbieden van cursussen en opleidingen met betrekking tot dit beroep.
  5. Alle diensten die in het bijzonder betrekking hebben op elektrotherapie,ergotherapie,fysiotherapie,endermologie,natuurgeneeskunde en nutritherapie.
  6. Revalidatie,medische gymnastiek,pre- en postnatale gymnastiek.
  7. Massage en fysiotherapie
  8. Verzorging van huisdieren,met uitzondering van diergeneeskundige zorg.
  9. In het algemeen alle paramedische technieken toepassen en zorg verlenen die verband houdt met fysiotherapie en osteopathie.
  10. De uitbating van een medische praktijk of een medisch centrum met als voorwerp het verstrekken van alle bovenstaande behandelingen en alle medische en paramedische beroepen.
  11. De aankoop,verkoop,import en export van alle apparatuur en toestellen,producten en benodigdheden die nodig zijn om bovengenoemde zorg te verlenen.
  12. Het aannemen van administratief en verplegend personeel.
  13. Het beheren en verhuren van medische en paramedische praktijken voor het uitoefenen van fysiotherapie en geneeskunde in het bijzonder en aanverwante praktijken in het algemeen.
  14. Het organiseren van opleidingen op medisch,sociaal of artistiek gebied,met inbegrip van het ter beschikking stellen van lokalen voor de organisatie van dergelijke activiteiten.
  15. Het organiseren van evenementen van wetenschappelijke,sociale of artistieke aard.
  16. Het ontwikkelen en promoten van opleidingen op verschillende gebieden om de kennis en de praktijk van de deelnemers te verbeteren.
  17. Het geven van remediërende en taalcursussen,inclusief het voorbereiden van kandidaten op vergelijkende examens.
  18. Het vervoer,voor eigen rekening of voor rekening van derden,van goederen,pakketten,koopwaar,documenten,diverse producten of andere goederen van welke aard dan ook.
  19. Het vervoer van personen
  20. De exploitatie van taxi's en personenvervoer met chauffeur en/of autoverhuur met chauffeur.
  21. Transacties met betrekking tot het beheer van haar privévermogen,en in het bijzonder de bouw,de inrichting,de decoratie,de verkoop,de aankoop,het beheer,de leasing in welke vorm dan ook,met inbegrip van de erfpacht van alle gebouwen en het meubilair dat deze inricht,en de ontwikkeling van alle onroerende goederen,evenals vastgoedontwikkeling en transformatieactiviteiten in het algemeen.
deed of 01-03-2024 (in Dutch)

Invoicing and payment

VAT number BE 0803.693.005
E-invoicing via Peppol
Reachable via Peppol
Peppol ID 0208:0803693005
Other Peppol ID 9925:BE0803693005
Registered 05-09-2025

Follow this company and you will hear the next morning if it leaves the Peppol register.

Register as of 2 November 2026 · Peppol Directory

Financial year and general meeting

Accounts at the NBB
Financial year end 30-06
Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
Second Tuesday of December at 18:00
deed of 01-03-2024 (in Dutch)

Sites & property

Location
registered office establishment The establishment unit on the map

Buildings and parcels at the address

Ground area
974 m²
Building footprint
110 m²
Cadastral parcel Region Area Buildings Height / floors
24085D0116/00F000 Flanders 974 m² 1 · 110 m² -